Boston Scientific (NYSE:BSX) Price Target Increased to $90.00 by Analysts at Citigroup
Boston Scientific (NYSE:BSX – Free Report) had its price objective raised by Citigroup from $87.00 to $90.00 in a research report released on Wednesday morning, Benzinga reports. The firm currently has a buy rating on the medical equipment provider’s stock. A number of other research firms have also issued reports on BSX. Evercore ISI increased […]
More Stories
State Attorneys General Sue BlackRock, Vanguard, State Street, Alleging Conspiracy Against Coal
By Kevin Stocklin Eleven state attorneys general, led by Texas Attorney General Ken Paxton, have filed an anti-trust suit against...
Short Interest in PIMCO New York Municipal Income Fund II (NYSE:PNI) Grows By 605.9%
PIMCO New York Municipal Income Fund II (NYSE:PNI – Get Free Report) was the recipient of a significant growth in...
Short Interest in Covestro AG (OTCMKTS:COVTY) Declines By 89.7%
Covestro AG (OTCMKTS:COVTY – Get Free Report) saw a significant decline in short interest during the month of November. As...
Short Interest in Synchronoss Technologies, Inc. 8.375% Senior Notes due 2026 (NASDAQ:SNCRL) Expands By 532.0%
Synchronoss Technologies, Inc. 8.375% Senior Notes due 2026 (NASDAQ:SNCRL – Get Free Report) was the recipient of a large increase...
nVent Electric plc (NYSE:NVT) Short Interest Up 55.3% in November
nVent Electric plc (NYSE:NVT – Get Free Report) saw a significant increase in short interest in the month of November....
FDA Issues Recall Alert for SunFed Cucumbers Due to Salmonella Risk
By Rudy Blalock The U.S. Food and Drug Administration (FDA) announced a recall of whole fresh American cucumbers Thursday that...